P. Spitzer

发表

Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage.

Claudio Babiloni, Fabrizio Vecchio, Beatriz Bosch, 2011, Journal of Alzheimer's disease : JAD.

Biochemical markers of neurodegeneration in hereditary diffuse leucoencephalopathy with spheroids

I. Blümcke, W. Brück, A. Dörfler, 2014, BMJ Case Reports.

Amyloid-β 42/40 cerebrospinal fluid concentration ratio in the diagnostics of Alzheimer's disease: validation of two novel assays.

P. Lewczuk, J. Kornhuber, P. Spitzer, 2014, Journal of Alzheimer's disease : JAD.

Amyloidogenic amyloid-β-peptide variants induce microbial agglutination and exert antimicrobial activity

Daniel F Gilbert, J. Kornhuber, P. Spitzer, 2016, Scientific Reports.

Pharmacological inhibition of APP processing and knock-down of APP in primary human macrophages impairs the secretion of cytokines

J. Kornhuber, P. Spitzer, J. Maler, 2019 .

Phagocytosis and LPS alter the maturation state of β-amyloid precursor protein and induce different Aβ peptide release signatures in human mononuclear phagocytes

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2010, Journal of Neuroinflammation.

Decreased circulating CD34+ stem cells in early Alzheimer's disease: evidence for a deficient hematopoietic brain support?

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2006, Molecular Psychiatry.

Urea‐based two‐dimensional electrophoresis of beta‐amyloid peptides in human plasma: Evidence for novel Aβ species

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2007, Proteomics.

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease

K. Blennow, P. Lewczuk, J. Kornhuber, 2015, Alzheimer's Research & Therapy.

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

K. Blennow, P. Lewczuk, J. Kornhuber, 2018, Alzheimer's Research & Therapy.

Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment

J. Winkler, E. Masliah, E. Rockenstein, 2014, Autophagy.

The Role of Cathepsin B in the Degradation of Aβ and in the Production of Aβ Peptides Starting With Ala2 in Cultured Astrocytes

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2021, Frontiers in Molecular Neuroscience.

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls

K. Blennow, P. Lewczuk, J. Kornhuber, 2015, Alzheimer's Research & Therapy.

Cerebrospinal Fluid of Patients With Alzheimer’s Disease Contains Increased Percentages of Synaptophysin-Bearing Microvesicles

J. Kornhuber, P. Spitzer, M. Herrmann, 2021, Frontiers in Aging Neuroscience.

Pharmacological Inhibition of Amyloidogenic APP Processing and Knock-Down of APP in Primary Human Macrophages Impairs the Secretion of Cytokines

J. Kornhuber, P. Spitzer, J. Maler, 2020, Frontiers in Immunology.

Analysis of Surface Levels of IL-1 Receptors and Macrophage Scavenger Receptor I in Peripheral Immune Cells of Patients With Alzheimer Disease

P. Lewczuk, J. Kornhuber, P. Spitzer, 2019, Journal of geriatric psychiatry and neurology.

cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases

K. Blennow, H. Soininen, L. Buée, 2010, International journal of Alzheimer's disease.

Astrocytes and microglia but not neurons preferentially generate N-terminally truncated Aβ peptides

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2015, Neurobiology of Disease.

Evidence for Elevated Cerebrospinal Fluid ERK1/2 Levels in Alzheimer Dementia

J. Schuchhardt, J. Wiltfang, L. Parnetti, 2011, International journal of Alzheimer's disease.

Clinical Study Evidence for Elevated Cerebrospinal Fluid ERK1/2 Levels in

J. Schuchhardt, J. Wiltfang, L. Parnetti, 2011 .

CD133-Positive Membrane Particles in Cerebrospinal Fluid of Patients with Inflammatory and Degenerative Neurological Diseases

S. Kloska, P. Spitzer, D. Corbeil, 2017, Front. Cell. Neurosci..

Imbalance of Circulating Th17 and Regulatory T Cells in Alzheimer’s Disease: A Case Control Study

J. Kornhuber, P. Spitzer, M. Herrmann, 2018, Front. Immunol..

Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization.

K. Blennow, J. Molinuevo, P. Lewczuk, 2016, Journal of Alzheimer's disease : JAD.

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

K. Blennow, P. Lewczuk, J. Kornhuber, 2018, Alzheimer's Research & Therapy.

A language-based sum score for the course and therapeutic intervention in primary progressive aphasia

A. Spottke, K. Fliessbach, H. Huppertz, 2018, Alzheimer's Research & Therapy.

App-based maintenance treatment for alcohol use disorder after acute inpatient treatment: Study protocol for a multicentre randomized controlled trial

M. Berking, P. Falkai, J. Kornhuber, 2022, Internet interventions.

CNS inflammation and neuronal degeneration is aggravated by impaired CD200–CD200R-mediated macrophage silencing

H. Wiendl, S. Meuth, P. Spitzer, 2008, Journal of Neuroimmunology.

Highly potent soluble amyloid-β seeds in human Alzheimer brain but not cerebrospinal fluid.

J. Wiltfang, M. Staufenbiel, H. Zetterberg, 2014, Brain : a journal of neurology.

N-truncation and pyroglutaminylation enhances the opsonizing capacity of Aβ-peptides and facilitates phagocytosis by macrophages and microglia

J. Kornhuber, P. Spitzer, M. Herrmann, 2014, Brain, Behavior, and Immunity.

Amyloid-β levels and cognitive trajectories in non-demented pTau181-positive subjects without amyloidopathy

P. Lewczuk, J. Kornhuber, P. Spitzer, 2022, Brain : a journal of neurology.

Adherence-dependent shifts in the patterns of β-amyloid peptides secreted by human mononuclear phagocytes

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2008, Brain, Behavior, and Immunity.

A Specific Reduction in Aβ1−42 vs. a Universal Loss of Aβ Peptides in CSF Differentiates Alzheimer's Disease From Meningitis and Multiple Sclerosis

P. Lewczuk, J. Kornhuber, P. Spitzer, 2018, Front. Aging Neurosci..

E-Learning Is Not Inferior to On-Site Teaching in a Psychiatric Examination Course

J. Kornhuber, P. Spitzer, C. Rauch, 2021, Frontiers in Psychiatry.

Microvesicles from cerebrospinal fluid of patients with Alzheimer’s disease display reduced concentrations of tau and APP protein

P. Lewczuk, J. Kornhuber, P. Spitzer, 2019, Scientific Reports.

A method to prevent cross contamination during 2‐DE by β‐amyloid peptides

J. Wiltfang, H. Klafki, P. Spitzer, 2010, Proteomics.

Distinct fractional Aβ release patterns in human mononuclear phagocytes

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2009, Journal of Neuroimmunology.

Low amounts of bisecting glycans characterize cerebrospinal fluid-borne IgG

G. Schett, P. Spitzer, R. Bilyy, 2018, Journal of Neuroimmunology.

HIGHLY POTENT SOLUBLE Aβ SEEDS IN HUMAN ALZHEIMER BRAIN BUT NOT CEREBROSPINAL FLUID

J. Wiltfang, M. Staufenbiel, M. Jucker, 2014, Alzheimer's & Dementia.

CNS inflammation and neuronal degeneration is aggravated by impaired CD200–CD200R-mediated macrophage silencing

H. Wiendl, S. Meuth, P. Spitzer, 2008, Journal of Neuroimmunology.